The Food and Drug Administration (FDA) is mulling a ban on ritodrine, a drug commonly used in Taiwan to suppress preterm labor, given that the European Union has done so for years due to hazardous side effects on expectant mothers.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Migrant caregiver flexibility program to take effect in March
02/06/2025 10:39 PM - Society
37 broadcasters could go off air due to understaffed NCC
02/06/2025 10:30 PM - Society
Babysitter ordered to pay over NT$14 million for assaulting infant
02/06/2025 09:46 PM - Cross-Strait
At least 30 people questioned over Chinese ID cards: Interior Ministry
02/06/2025 09:34 PM - Science & Tech